Paediatric Medicines

22

Jun, 2021

The birth of the UNIVERSAL project – a back story

A while ago, we sat with Marc Lallemant – the scientific coordinator of the UNIVERSAL project led by Penta, for a quick chat. It was an eye-opening discussion that delved into the early beginnings and the birth of the project. According to Marc, TUTI pronounced as “tutti” in Italian (meaning everyone) was the name initially settled for. He further went on to clarify that TUTI had no Italian origin and was an acronym with a full meaning – Towards Universal Treatment of children in Africa. It was from this acronym […]

11

Mar, 2021

GAP-f webinar on Best practices in clinical research for the development of paediatric formulations

Tags: Paediatric Medicines

We are pleased to invite you to the kick-off of #BetterDrugs4Kids, GAP-f’s new quarterly webinar series on paediatric drug optimization, featuring deep dives on paediatric drug prioritization, evaluation, development, and delivery, and promoting discussions to close the paediatric treatment gaps. The first webinar, on “Best practices in clinical research for the development of paediatric formulations”, is hosted by GAP-f’s Clinical Research Working Group, led by Penta. The webinar will be an opportunity to reflect on concrete innovations for optimizing efforts and more rapidly generate the evidence needed to inform the […]

10

Dec, 2020

Cascade of care in children and adolescents with HIV in the Russian Federation

Tags: HIV, Paediatric Medicines, REACH

The Cascade of Care, more commonly known as the HIV care continuum, is a calculation of how many people in a specific population diagnosed with HIV are initially linked to care, retained in care and have achieved viral suppression. It is an important tool in measuring success in controlling the HIV infection, identifying gaps in national HIV/AIDS strategies and set directions to improve care. On behalf of EPIICC and REACH researchers, Anna Turkova presented on the Cascade of Care of HIV positive children and adolescents in three Russian centres at […]

10

Dec, 2020

Cascade of care in children and adolescents with HIV in Russian Federation

Tags: HIV, Paediatric Medicines

Author: Anna Turkova, Evgeny Voronin, Yulia Plotnikova, Anna Samarina, Edith Milanzi, Vladimir Rozenberg, Liubov Okhonskaia, Inga Latysheva, Aleksey Plynsky, Elena Fertikh, Siobhan Crichton, Charlotte Jackson, Ali Judd, Intira J Collins, on behalf of the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Published in: 12th International Workshop on HIV Pediatrics View Poster Background: The cascade of care summarises the 90-90-90 UNAIDS targets, of 90% of HIV+ people knowing their status, of whom 90% receive antiretroviral treatment (ART), of whom 90% are virally suppressed By 2019, there were 1,068,839 people […]

4

Dec, 2020

Pediatric dolutegravir (DTG) dosing recommendations derived from combined P1093 and ODYSSEY Population Pharmacokinetic analysis

Tags: HIV, Paediatric Medicines

Authors: Singh R, Baker M, Thapar M, Gibb D, Turkova A, Ford D, Ruel T, Wiznia A, Farhad M, Alvero C, Green J, Bollen P, Colbers A, Burger D, Acosta E Published in: 12th International Workshop on HIV Pediatrics View Abstract booklet Background: HIV treatment options remain limited in children. The recent Tivicay (dolutegravir, DTG) pediatric regulatory submissions propose WHO weight-band based recommendations for once-daily dosing in children ≥4 weeks of age using combined datasets from two pediatric studies: IMPAACT P1093 and ODYSSEY (PENTA20). These doses were informed by […]

16

Oct, 2020

8th Congress of the European Academy of Paediatric Societies: Virtual

Tags: Paediatric Medicines

Shaping the Future of Child Health The combined efforts and talents of the best and brightest minds in paediatrics have turned this biannual event into a major educational and research platform, attracting high quality scientific presentations that have subsequently appeared in high-impact journals. Joins us to learn more about the leaps and bounds that have been made in child health care. Find all the event registration details here.

14

Oct, 2020

SARS-CoV-2 testing and infection control strategies in European paediatric emergency departments during the first wave of the pandemic

Tags: Paediatric Medicines, Infectious Disease, COVID-19

European Journal of Pediatics, October 2020

4

Feb, 2019

ILF: Advance procurement of paediatric drug formulations – Policy brief

Tags: HIV, Paediatric Medicines, AIDS, ILF

The many challenges of developing drugs appropriately formulated for children are compounded by a series of market factors that make these efforts costly and complex, discouraging drug manufacturers – especially generic drug manufacturers – from prioritizing investments in new paediatric treatment options.

28

Mar, 2018

Accelerating Paediatric Formulation Development – SPaeDD project meeting in London

Tags: EPTRI, Paediatric Medicines

The meeting aims to provide an update on Contemporary Paediatrics and to present the outputs of the SPaeDD-UK Project.
Co-funded by Innovate UK (the UK’s Innovation Agency, the Smart Paediatric Drug Development (SPaeDD) initiative is a cross company and academic centre initiative to accelerate paediatric formulation development.

2

Feb, 2018

A video of the ID-EPTRI Kick-off meeting now available!

Tags: EPTRI, Paediatric Medicines

The active participation and the strong interest shown by more of the 100 participants has confirmed that the ID-EPTRI project can count on a collaborative and proficient partnership

News

The birth of the UNIVERSAL project – a back story

GAP-f webinar on Best practices in clinical research for the development of paediatric formulations

Cascade of care in children and adolescents with HIV in the Russian Federation

Cascade of care in children and adolescents with HIV in Russian Federation

Pediatric dolutegravir (DTG) dosing recommendations derived from combined P1093 and ODYSSEY Population Pharmacokinetic analysis

8th Congress of the European Academy of Paediatric Societies: Virtual

SARS-CoV-2 testing and infection control strategies in European paediatric emergency departments during the first wave of the pandemic

ILF: Advance procurement of paediatric drug formulations – Policy brief

Accelerating Paediatric Formulation Development – SPaeDD project meeting in London

A video of the ID-EPTRI Kick-off meeting now available!

Dolutegravir-based ART is superior to NNRTI- and PI-based ART in infants, children and adolescents living with HIV (combined results of the main trial and the ‘under 14kg’ cohort)

Early Impact of SARS-CoV-2 on Pediatric Clinical Research: A Pan-European and Canadian Snapshot in Time

Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents